Tag Archives: 2011

2011 AIChE Annual Meeting Highlights

The 2011 American Institute of Chemical Engineers (AIChE) Annual Meeting took place October 16 to 21 in Minneapolis, MN.  The AIChE Annual Meeting is a terrific event to: Continue reading

What is Happening in Crystallization

Here is what is happening in crystallization: Continue reading

AIChE征集结晶技术报告

美国化学工程师学会(AIChE)2011年会将在十月16-21 日于Minneapolis, MN 举行,有几个分会将重点讨论结晶于蒸发。

2011 AIChE
Bing-Shiou Yang (Principal Engineer, Boehringer Ingelheim) 和我将主持用于结晶开发与生产的PAT 分会。本分会欢迎新进的把工艺过程分析技术(PAT)应用于结晶工艺过程开发和生产的技术报告。 PAT应用技术可包括各种光谱分析法(FTIR, NIR, Raman)、颗粒与计数技术、以及其它不同在线监测或传感技术。尤其感兴趣的是驱动结晶过程开发的创新性途径和手段。 Continue reading

Upcoming Continuous Flow Chemistry Events

Regular visitors to this blog will be familiar with recent continuous flow chemistry events in what I consider to be a very exciting, fast-developing area of chemistry. When I was reading the recent blog post regarding the upcoming Pfizer Flow Technology Expo, I thought about other upcoming flow chemistry events, including: Continue reading

AIChE Call For Crystallization Papers

The 2011 American Institute of Chemical Engineers (AIChE) Annual Meeting – to be held October 16-21 in Minneapolis, MN – features a number of sessions on crystallization and evaporation.  Continue reading

IFPAC 2011上谈PAT与颗粒大小分析

2010工艺过程中的颗粒论坛会上的三位报告者将在2011年1月21日于(美国)马里兰州的巴尔的摩举行的IFPAC (工艺过程分析技术国际论坛)上作报告。Johnson & Johnson的Steve Mehrman和Merck & Co. 的James Butz被排在周五上午的“颗粒特征分析超声光谱”IFPAC 的第五分会作报告。Bristol-Myers Squibb的Kevin Macias将在周五上午的“药品开发与生产的控制战略”第七分会中作报告。 Continue reading

PAT & Particle Size Analysis at IFPAC 2011

Three speakers from the 2010 In-Process Particle Forum will present at IFPAC [International Forum Process Analytical Technology] on January 21, 2011 in Baltimore, MD.  Steve Mehrman  of Johnson & Johnson and James Butz of Merck & Co. are scheduled to present during the Particle Characterization/Analysis-Ultrasound Spectroscopy Friday AM V session at IFPAC.  Kevin Macias of Bristol-Myers Squibb will present during the Control Strategies for Drug Product Development and Manufacturing Friday AM VII session. Continue reading